PhaseRx, a Seattle-based biotech startup focused on delivering therapies via sIRNA, has raised $19 million in first-round funding. Backers include 5AM Ventures, Arch Venture Partners and Versant Ventures. The company was founded by Robert Overall, a former general partner with Frazier Healthcare Ventures. Get more info.
Home News Briefs PhaseRx Raises $19 Million